ArticleFrontiers in immunology2026

Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis.

Qi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.